From: Diabetes management in Thailand: a literature review of the burden, costs, and outcomes
Cost of complications | Summary of the main features of the study | References |
---|---|---|
Median cost per year (USD$ at 2008 prices) of diabetes for patients: | Study year: 2007-2008 | [60] |
With complications: USD$ 480 (n = 148, SD = 3,023) | Setting: Waritchaphum hospital in Sakhon Nakhon province (North-East Thailand) | |
Without complications: USD$ 115 (n = 327, SD = 2,648) | Sample and study design: 475 randomly selected diabetic patients | |
Independent: USD$ 124 (n = 411, SD = 2,152) |  | |
Any level of disability: USD$ 811 (n = 61, SD = 4,982) |  | |
Mildly disabled: USD$ 668 (n = 51, SD = 3,848) |  | |
Moderate disability: USD$ 2,374 (n = 7, SD = 7,940) |  | |
Severely disabled: USD$ 4,891 (n = 1, SD = 0) |  | |
Very severely disabled: USD$ 4,378 (n = 5, SD = 7,622) |  | |
Average spending per hospital admission as percentage of GDP per capita and in USD (constant 2000): | Study year: 2006-2008 | [61] USD equivalents of the percentage of GDP spent per hospital admission were calculated by the authors using GDP data (USD constant 2000, 2,712 in 2007) from The World Bank. |
Total: 62% (USD$ 1682) | Setting: University hospital in Bangkok | |
without complications: 49% (USD$ 1,329) | Sample and study design: The study included all 8,596 (94% insured, 6% uninsured) DM patients admitted in the hospital during 2006-2008. Retrospective data analysis. | |
with myocardial infarction: 108% (USD$ 2,930) | Â | |
with congestive heart failure: 93% (USD$ 2523) | Â | |
with peripheral vascular disease: 116% (USD$ 3147) | Â | |
with ulcer: 106% (USD$ 2,876) | Â | |
with hemiplegia: 63% (USD$ 1,709) | Â | |
with moderate/severe renal disease: 90% (USD$ 2,442) | Â | |
Median cost of illness per year: | Study year: 2007-2008 | |
With complications USD$ 480 (n = 148, IQR = 129-1552) | Setting: Waritchaphum hospital in Sakhon Nakhon province (North-East Thailand) | |
Without complications USD$ 115 (n = 327, IQR = 74-286) | Sample and study design: 475 randomly selected diabetic patients. Micro-costing approach. | |
With microvascular complications USD$ 641 (n = 59, IQR = 207-2,268) |  | |
With macrovascular complications USD$ 367 (n = 11, IQR = 111-2,463) |  | |
With micro- and macrovascular complications USD$ 666 (n = 11, IQR = 201-2,707) |  | |
With microvascular complications and cataract USD$ 745 (n = 23, IQR = 376-1,358) |  | |
Cataract USD$ 151 (n = 44, IQR = 94-587) |  | |
Predicted cost per year of DM T2 (N = 186): | Study year: 2001 | [52] |
without complications USD$ 101 (BHT 4,037) | Setting: 30-bed public hospital in central Thailand | |
with hypertension USD$ 117 (BHT 4,686) | Sample and study design: 186 diabetic patients. Retrospective prevalence-based cost of illness study. Multiple regression analysis was used to predict cost of DM for various types of complications. | |
with hyperlipidaemia USD$ 144 (BHT 5,775) | Â | |
with diabetic foot USD$ 190 (BHT 7,603) | Â | |
with hyperglycaemia USD$ 209 (BHT 8,369) | Â | |
with hypoglycaemia USD$ 247 (BHT 9,860) | Â | |
with cerebrovascular accident USD$ 260 (BHT 10,418) | Â | |
with gangrene USD$ 336 (BHT 13,417) | Â | |
(40 THB = 1 USD$ at 2011 prices) |  |  |